

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 7.30327147 |
| 2 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 6.51839428 |
| 3 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 6.51839428 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.08449813 |
| 5 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.06922764 |
| 6 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.81072125 |
| 7 | regulation of growth of symbiont in host (GO:0044126) | 5.81072125 |
| 8 | negative regulation of growth of symbiont in host (GO:0044130) | 5.81072125 |
| 9 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.81072125 |
| 10 | respiratory burst (GO:0045730) | 5.74676228 |
| 11 | myeloid leukocyte mediated immunity (GO:0002444) | 5.69598571 |
| 12 | negative regulation of cell killing (GO:0031342) | 5.65811913 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.65811913 |
| 14 | response to peptidoglycan (GO:0032494) | 5.50702852 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 5.45874809 |
| 16 | response to fungus (GO:0009620) | 5.34514673 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 5.08808568 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 5.08808568 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.08808568 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.08808568 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.08808568 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 5.08808568 |
| 23 | leukocyte mediated cytotoxicity (GO:0001909) | 5.02691665 |
| 24 | detection of bacterium (GO:0016045) | 4.92408424 |
| 25 | reactive oxygen species biosynthetic process (GO:1903409) | 4.91422539 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.88517360 |
| 27 | disruption of cells of other organism (GO:0044364) | 4.84514503 |
| 28 | killing of cells of other organism (GO:0031640) | 4.84514503 |
| 29 | defense response to fungus (GO:0050832) | 4.82565662 |
| 30 | leukocyte aggregation (GO:0070486) | 4.70698816 |
| 31 | detection of external biotic stimulus (GO:0098581) | 4.68088589 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65164097 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 4.48327615 |
| 34 | cellular response to zinc ion (GO:0071294) | 4.43905973 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.42008442 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.26229863 |
| 37 | detection of biotic stimulus (GO:0009595) | 4.20474848 |
| 38 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.18673956 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.15125081 |
| 40 | neutrophil activation (GO:0042119) | 4.14551013 |
| 41 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.99705442 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 3.98025038 |
| 43 | granulocyte activation (GO:0036230) | 3.89154101 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.88727007 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.86090447 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79291184 |
| 47 | cell killing (GO:0001906) | 3.76928670 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.75861051 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.75271321 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.73154822 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.64384399 |
| 52 | superoxide anion generation (GO:0042554) | 3.64136969 |
| 53 | response to host immune response (GO:0052572) | 3.62827181 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.62827181 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.60666747 |
| 56 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.57241183 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 3.51967698 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.50436742 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.45054806 |
| 60 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.44768449 |
| 61 | regulation of mast cell activation (GO:0033003) | 3.44290218 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.42968578 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.41167578 |
| 64 | mast cell activation (GO:0045576) | 3.39832524 |
| 65 | leukotriene metabolic process (GO:0006691) | 3.38423520 |
| 66 | regulation of tolerance induction (GO:0002643) | 3.37295114 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36505577 |
| 68 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36505577 |
| 69 | regulation of chemokine biosynthetic process (GO:0045073) | 3.36447913 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.35602284 |
| 71 | B cell mediated immunity (GO:0019724) | 3.33123677 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 3.31956311 |
| 73 | cellular extravasation (GO:0045123) | 3.30477200 |
| 74 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.28540351 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.25524109 |
| 76 | response to muramyl dipeptide (GO:0032495) | 3.24629545 |
| 77 | response to host (GO:0075136) | 3.24415320 |
| 78 | response to host defenses (GO:0052200) | 3.24415320 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.24415320 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.24132586 |
| 81 | sequestering of metal ion (GO:0051238) | 3.23022229 |
| 82 | pinocytosis (GO:0006907) | 3.21969324 |
| 83 | defense response to protozoan (GO:0042832) | 3.21660509 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.18437116 |
| 85 | natural killer cell mediated immunity (GO:0002228) | 3.15197257 |
| 86 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.15197257 |
| 87 | regulation of regulated secretory pathway (GO:1903305) | 3.15055454 |
| 88 | leukocyte degranulation (GO:0043299) | 3.14046598 |
| 89 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.13354639 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12159839 |
| 91 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11922211 |
| 92 | regulation of T cell tolerance induction (GO:0002664) | 3.09851193 |
| 93 | negative regulation of mast cell activation (GO:0033004) | 3.08864847 |
| 94 | positive thymic T cell selection (GO:0045059) | 3.07694310 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03931531 |
| 96 | leukocyte mediated immunity (GO:0002443) | 3.03875659 |
| 97 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.02243521 |
| 98 | response to interleukin-15 (GO:0070672) | 3.01724133 |
| 99 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01243717 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.00291250 |
| 101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00040318 |
| 102 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.99727494 |
| 103 | regulation of B cell differentiation (GO:0045577) | 2.99536988 |
| 104 | activated T cell proliferation (GO:0050798) | 2.99433432 |
| 105 | cellular response to interferon-beta (GO:0035458) | 2.98362847 |
| 106 | response to protozoan (GO:0001562) | 2.96612151 |
| 107 | positive regulation of leukocyte degranulation (GO:0043302) | 2.94635525 |
| 108 | neutrophil chemotaxis (GO:0030593) | 2.93884259 |
| 109 | regulation of leukocyte degranulation (GO:0043300) | 2.93475767 |
| 110 | actin nucleation (GO:0045010) | 2.91917941 |
| 111 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.90920612 |
| 112 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.89549144 |
| 113 | T cell migration (GO:0072678) | 2.87167496 |
| 114 | negative thymic T cell selection (GO:0045060) | 2.86798529 |
| 115 | neutrophil migration (GO:1990266) | 2.85300805 |
| 116 | detection of other organism (GO:0098543) | 2.84758267 |
| 117 | angiogenesis involved in wound healing (GO:0060055) | 2.84436742 |
| 118 | type I interferon signaling pathway (GO:0060337) | 2.83995258 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.83995258 |
| 120 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.83558782 |
| 121 | microglial cell activation (GO:0001774) | 2.81531064 |
| 122 | response to type I interferon (GO:0034340) | 2.81254979 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81155682 |
| 124 | positive regulation of regulated secretory pathway (GO:1903307) | 2.80365633 |
| 125 | negative T cell selection (GO:0043383) | 2.80005901 |
| 126 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79733227 |
| 127 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.79576579 |
| 128 | macrophage differentiation (GO:0030225) | 2.79551314 |
| 129 | myeloid leukocyte activation (GO:0002274) | 2.76272460 |
| 130 | negative regulation of interleukin-8 production (GO:0032717) | 2.75920510 |
| 131 | leukotriene biosynthetic process (GO:0019370) | 2.75662170 |
| 132 | macrophage activation (GO:0042116) | 2.75285185 |
| 133 | response to interferon-beta (GO:0035456) | 2.74922673 |
| 134 | positive regulation of mast cell degranulation (GO:0043306) | 2.73661452 |
| 135 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.73661452 |
| 136 | negative regulation of interleukin-12 production (GO:0032695) | 2.72785375 |
| 137 | negative regulation of interleukin-17 production (GO:0032700) | 2.71978492 |
| 138 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70248652 |
| 139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65545755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.54899700 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.26458604 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81751745 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.92734375 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.87104956 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.76158363 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51590209 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.42983904 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.18976445 |
| 10 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.16251267 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12732564 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83307308 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.73630682 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71785805 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.60659752 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.57514975 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55906631 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55256512 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.41883190 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41763674 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40952431 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.30817111 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24035387 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23504608 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19757160 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.18114187 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.16789167 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12374319 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11007724 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01540360 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01290198 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95466570 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.93967209 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.81634346 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81533248 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79132646 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78859164 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77519822 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75725450 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.69603414 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65813362 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.60841685 |
| 43 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55544713 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.55087474 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.55019683 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54970851 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53943433 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51997430 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50683885 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48921097 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.48074298 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47356408 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45909746 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44090745 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43895339 |
| 56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41633365 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.41066688 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40588562 |
| 59 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39340239 |
| 60 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38985439 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38761784 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37818397 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37299404 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35967647 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34874760 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34541536 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32705692 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32126544 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31169763 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29824851 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29033705 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26086017 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24451318 |
| 74 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22793044 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22538214 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18530532 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17836140 |
| 78 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17636756 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15472119 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13125777 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11448722 |
| 82 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09577207 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08885912 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08618697 |
| 85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08215922 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08131424 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07360960 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06313265 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05238183 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05157778 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05040086 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04507979 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04266682 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04057872 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03280407 |
| 96 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01455541 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01190606 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99632242 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94393233 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91935505 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.91115985 |
| 102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90663270 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90469566 |
| 104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90038429 |
| 105 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89216786 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89182861 |
| 107 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88126873 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86782781 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.85462659 |
| 110 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84123398 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83157731 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 0.82462322 |
| 113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81666227 |
| 114 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.81349517 |
| 115 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.80806634 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78517336 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78493810 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77870250 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77732855 |
| 120 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77485082 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.77258492 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76756328 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76591699 |
| 124 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75052409 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.72168386 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70144269 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69493514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.19801045 |
| 2 | MP0003436_decreased_susceptibility_to | 4.07505294 |
| 3 | MP0009785_altered_susceptibility_to | 3.57642826 |
| 4 | MP0003303_peritoneal_inflammation | 3.51504059 |
| 5 | MP0002419_abnormal_innate_immunity | 3.49711943 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.06456120 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.99809919 |
| 8 | MP0005025_abnormal_response_to | 2.94480395 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.83366217 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.78328545 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.63881517 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.61619356 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.47940604 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.46243847 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.37568361 |
| 16 | MP0003724_increased_susceptibility_to | 2.34177221 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.33109990 |
| 18 | MP0001819_abnormal_immune_cell | 2.32660376 |
| 19 | MP0001800_abnormal_humoral_immune | 2.30496925 |
| 20 | MP0002723_abnormal_immune_serum | 2.28272904 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.22375523 |
| 22 | MP0005387_immune_system_phenotype | 2.16042127 |
| 23 | MP0001790_abnormal_immune_system | 2.16042127 |
| 24 | MP0000685_abnormal_immune_system | 2.06029459 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.04905473 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.02708359 |
| 27 | MP0005671_abnormal_response_to | 2.02097024 |
| 28 | MP0002006_tumorigenesis | 1.90177894 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.85117783 |
| 30 | MP0002405_respiratory_system_inflammati | 1.84848672 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.82238322 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.82238322 |
| 33 | MP0003693_abnormal_embryo_hatching | 1.81797227 |
| 34 | MP0001853_heart_inflammation | 1.81573091 |
| 35 | MP0006082_CNS_inflammation | 1.79838409 |
| 36 | MP0002398_abnormal_bone_marrow | 1.79650460 |
| 37 | MP0000716_abnormal_immune_system | 1.77542643 |
| 38 | MP0000858_altered_metastatic_potential | 1.75912632 |
| 39 | MP0000343_altered_response_to | 1.71981387 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.71661980 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.65972833 |
| 42 | MP0010307_abnormal_tumor_latency | 1.62072274 |
| 43 | MP0000490_abnormal_crypts_of | 1.61208038 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.60599273 |
| 45 | MP0002132_abnormal_respiratory_system | 1.59732587 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.58236767 |
| 47 | MP0009278_abnormal_bone_marrow | 1.52707959 |
| 48 | MP0002429_abnormal_blood_cell | 1.52582367 |
| 49 | MP0008469_abnormal_protein_level | 1.49644677 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.49310213 |
| 51 | MP0002722_abnormal_immune_system | 1.46507432 |
| 52 | MP0009764_decreased_sensitivity_to | 1.43651997 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.40743821 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.39989914 |
| 55 | MP0003075_altered_response_to | 1.35945534 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.35843578 |
| 57 | MP0003448_altered_tumor_morphology | 1.35822939 |
| 58 | MP0005451_abnormal_body_composition | 1.32476510 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.29175771 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.27651675 |
| 61 | MP0008057_abnormal_DNA_replication | 1.26995884 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.25818647 |
| 63 | MP0008004_abnormal_stomach_pH | 1.21223807 |
| 64 | MP0004381_abnormal_hair_follicle | 1.19478106 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 1.18690890 |
| 66 | MP0004947_skin_inflammation | 1.12886316 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.10228689 |
| 68 | MP0003077_abnormal_cell_cycle | 1.10051902 |
| 69 | MP0003186_abnormal_redox_activity | 1.08387547 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.06491076 |
| 71 | MP0000604_amyloidosis | 1.05686233 |
| 72 | MP0001873_stomach_inflammation | 1.04079021 |
| 73 | MP0001851_eye_inflammation | 1.03097560 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.01984909 |
| 75 | MP0009763_increased_sensitivity_to | 0.99577399 |
| 76 | MP0002095_abnormal_skin_pigmentation | 0.99476352 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.98040520 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.97471247 |
| 79 | MP0005310_abnormal_salivary_gland | 0.97245031 |
| 80 | MP0009840_abnormal_foam_cell | 0.95793815 |
| 81 | MP0001663_abnormal_digestive_system | 0.92877645 |
| 82 | MP0005164_abnormal_response_to | 0.92508872 |
| 83 | MP0004510_myositis | 0.91849998 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.91751880 |
| 85 | MP0000371_diluted_coat_color | 0.91032340 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.87609221 |
| 87 | MP0005166_decreased_susceptibility_to | 0.85487175 |
| 88 | MP0005390_skeleton_phenotype | 0.82188112 |
| 89 | MP0000249_abnormal_blood_vessel | 0.81710302 |
| 90 | MP0006054_spinal_hemorrhage | 0.79026255 |
| 91 | MP0003866_abnormal_defecation | 0.77600348 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.76725174 |
| 93 | MP0003690_abnormal_glial_cell | 0.74259015 |
| 94 | MP0008058_abnormal_DNA_repair | 0.72843603 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.71088618 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.70217170 |
| 97 | MP0008873_increased_physiological_sensi | 0.69972832 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.68628908 |
| 99 | MP0002933_joint_inflammation | 0.66893428 |
| 100 | MP0003828_pulmonary_edema | 0.65740187 |
| 101 | MP0000313_abnormal_cell_death | 0.65570569 |
| 102 | MP0002009_preneoplasia | 0.64680469 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.63065065 |
| 104 | MP0004130_abnormal_muscle_cell | 0.62605997 |
| 105 | MP0008874_decreased_physiological_sensi | 0.62365933 |
| 106 | MP0004957_abnormal_blastocyst_morpholog | 0.62347537 |
| 107 | MP0003045_fibrosis | 0.61026033 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.58537399 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56756749 |
| 110 | MP0003795_abnormal_bone_structure | 0.56745111 |
| 111 | MP0003091_abnormal_cell_migration | 0.56175892 |
| 112 | MP0005083_abnormal_biliary_tract | 0.56042122 |
| 113 | MP0004883_abnormal_blood_vessel | 0.55923572 |
| 114 | MP0004484_altered_response_of | 0.55386235 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.54540140 |
| 116 | MP0005388_respiratory_system_phenotype | 0.53473418 |
| 117 | MP0002133_abnormal_respiratory_system | 0.53473418 |
| 118 | MP0008260_abnormal_autophagy | 0.52931692 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.52779297 |
| 120 | MP0000920_abnormal_myelination | 0.52583239 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.50869100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.60353869 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.92381662 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.43723822 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.34312811 |
| 5 | Chronic obstructive pulmonary disease (HP:0006510) | 5.22035766 |
| 6 | Obstructive lung disease (HP:0006536) | 5.22035766 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.62392670 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.48316428 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.48101731 |
| 10 | Thrombocytosis (HP:0001894) | 4.47965151 |
| 11 | Myositis (HP:0100614) | 4.43670318 |
| 12 | Recurrent skin infections (HP:0001581) | 4.06833883 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.94421804 |
| 14 | Periodontitis (HP:0000704) | 3.92870131 |
| 15 | Abnormality of the prostate (HP:0008775) | 3.90563444 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.88437653 |
| 17 | Gingivitis (HP:0000230) | 3.85159184 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.63729583 |
| 19 | Meningitis (HP:0001287) | 3.48201463 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.47474527 |
| 21 | Stomatitis (HP:0010280) | 3.45300164 |
| 22 | Orchitis (HP:0100796) | 3.37378812 |
| 23 | Eosinophilia (HP:0001880) | 3.23386696 |
| 24 | Papilledema (HP:0001085) | 3.15904561 |
| 25 | Recurrent viral infections (HP:0004429) | 3.15686423 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.13470065 |
| 27 | T lymphocytopenia (HP:0005403) | 3.13023032 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.12894834 |
| 29 | Optic neuritis (HP:0100653) | 3.12894834 |
| 30 | Agnosia (HP:0010524) | 3.08678979 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.01496911 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01265268 |
| 33 | Vasculitis (HP:0002633) | 3.01002413 |
| 34 | Cellulitis (HP:0100658) | 3.00437003 |
| 35 | Granulocytopenia (HP:0001913) | 2.96004069 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.93996952 |
| 37 | Episodic fever (HP:0001954) | 2.92288594 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.91392204 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.91392204 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.91392204 |
| 41 | Chronic otitis media (HP:0000389) | 2.90272110 |
| 42 | Disinhibition (HP:0000734) | 2.88712524 |
| 43 | Petechiae (HP:0000967) | 2.87977857 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.86274242 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.85524265 |
| 46 | Increased IgE level (HP:0003212) | 2.80946401 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.80911866 |
| 48 | Leukocytosis (HP:0001974) | 2.78695406 |
| 49 | Peritonitis (HP:0002586) | 2.76342420 |
| 50 | Urticaria (HP:0001025) | 2.72560077 |
| 51 | Pulmonary embolism (HP:0002204) | 2.71023750 |
| 52 | Purpura (HP:0000979) | 2.69631015 |
| 53 | Basal ganglia calcification (HP:0002135) | 2.67801504 |
| 54 | Chest pain (HP:0100749) | 2.65944289 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.64604732 |
| 56 | IgM deficiency (HP:0002850) | 2.62617431 |
| 57 | Recurrent pneumonia (HP:0006532) | 2.61167411 |
| 58 | Anorexia (HP:0002039) | 2.61120908 |
| 59 | Hemoptysis (HP:0002105) | 2.60507408 |
| 60 | Osteomyelitis (HP:0002754) | 2.59464859 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59172995 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.59172995 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.57004486 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 2.54225647 |
| 65 | Abnormality of T cells (HP:0002843) | 2.53456734 |
| 66 | Abnormal platelet volume (HP:0011876) | 2.50289677 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.49804554 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.49056480 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.47549496 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45750675 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45750675 |
| 72 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45750675 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.42913608 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.42404647 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41312131 |
| 76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41312131 |
| 77 | Chromsome breakage (HP:0040012) | 2.40566991 |
| 78 | Increased IgM level (HP:0003496) | 2.40054231 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.39284607 |
| 80 | B lymphocytopenia (HP:0010976) | 2.39284607 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.36877950 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.35169990 |
| 83 | Hypochromic anemia (HP:0001931) | 2.34007989 |
| 84 | Sepsis (HP:0100806) | 2.31128187 |
| 85 | Abnormality of eosinophils (HP:0001879) | 2.30640350 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.30040864 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29886108 |
| 88 | Gangrene (HP:0100758) | 2.29610179 |
| 89 | Vertigo (HP:0002321) | 2.26098591 |
| 90 | Pustule (HP:0200039) | 2.24704513 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.24160103 |
| 92 | Prostate neoplasm (HP:0100787) | 2.23454244 |
| 93 | Increased serum ferritin (HP:0003281) | 2.22854579 |
| 94 | Skin ulcer (HP:0200042) | 2.21331561 |
| 95 | Epistaxis (HP:0000421) | 2.20617831 |
| 96 | Amaurosis fugax (HP:0100576) | 2.20355827 |
| 97 | Recurrent lower respiratory tract infections (HP:0002783) | 2.19566228 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.19278742 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.18100044 |
| 100 | Colitis (HP:0002583) | 2.16506107 |
| 101 | Loss of speech (HP:0002371) | 2.15376311 |
| 102 | Abnormality of the peritoneum (HP:0002585) | 2.14623986 |
| 103 | Axonal loss (HP:0003447) | 2.13577089 |
| 104 | Keratoconjunctivitis (HP:0001096) | 2.11890716 |
| 105 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.11480615 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 2.11204186 |
| 107 | Pulmonary fibrosis (HP:0002206) | 2.08448317 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.07097404 |
| 109 | Abnormality of the endocardium (HP:0004306) | 2.06430825 |
| 110 | Polyneuropathy (HP:0001271) | 2.04292253 |
| 111 | Thrombophlebitis (HP:0004418) | 2.01367525 |
| 112 | Acute hepatic failure (HP:0006554) | 1.99419790 |
| 113 | Abnormality of the thoracic spine (HP:0100711) | 1.98811162 |
| 114 | Arterial thrombosis (HP:0004420) | 1.97460734 |
| 115 | Microcytic anemia (HP:0001935) | 1.97216182 |
| 116 | Poikiloderma (HP:0001029) | 1.96896419 |
| 117 | Reticulocytopenia (HP:0001896) | 1.96275559 |
| 118 | Restrictive lung disease (HP:0002091) | 1.96184846 |
| 119 | Albinism (HP:0001022) | 1.95951116 |
| 120 | Abnormality of male internal genitalia (HP:0000022) | 1.94787731 |
| 121 | Cheilitis (HP:0100825) | 1.94206501 |
| 122 | Duplicated collecting system (HP:0000081) | 1.93119495 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.92434254 |
| 124 | Glomerulonephritis (HP:0000099) | 1.92408668 |
| 125 | Skin rash (HP:0000988) | 1.92131142 |
| 126 | Joint hemorrhage (HP:0005261) | 1.91000378 |
| 127 | Type I transferrin isoform profile (HP:0003642) | 1.90876338 |
| 128 | Glomerulopathy (HP:0100820) | 1.90083865 |
| 129 | Fatigue (HP:0012378) | 1.89997554 |
| 130 | Neutropenia (HP:0001875) | 1.89739774 |
| 131 | Poor head control (HP:0002421) | 1.88770312 |
| 132 | Menorrhagia (HP:0000132) | 1.87586080 |
| 133 | Agammaglobulinemia (HP:0004432) | 1.87465355 |
| 134 | Gingival bleeding (HP:0000225) | 1.86684307 |
| 135 | Encephalitis (HP:0002383) | 1.86630534 |
| 136 | Amyloidosis (HP:0011034) | 1.86403486 |
| 137 | Viral hepatitis (HP:0006562) | 1.86119628 |
| 138 | Increased mean platelet volume (HP:0011877) | 1.86030119 |
| 139 | Keratitis (HP:0000491) | 1.85512894 |
| 140 | Polycythemia (HP:0001901) | 1.84054682 |
| 141 | Acne (HP:0001061) | 1.83515797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.89870437 |
| 2 | BLK | 3.31597727 |
| 3 | RIPK4 | 3.19724009 |
| 4 | MAP3K14 | 2.93050700 |
| 5 | KIT | 2.80593376 |
| 6 | IRAK3 | 2.64920058 |
| 7 | MAP4K1 | 2.61627614 |
| 8 | TAOK3 | 2.57291863 |
| 9 | TEC | 2.48724011 |
| 10 | TYK2 | 2.20617669 |
| 11 | FES | 2.14709317 |
| 12 | PRPF4B | 2.09634321 |
| 13 | BTK | 2.07888652 |
| 14 | FGR | 2.02724016 |
| 15 | TBK1 | 2.00252113 |
| 16 | PIM2 | 1.96426487 |
| 17 | TNK2 | 1.93574721 |
| 18 | MAP2K3 | 1.83409647 |
| 19 | SYK | 1.73942873 |
| 20 | ERN1 | 1.66636923 |
| 21 | IKBKE | 1.62302637 |
| 22 | MAP3K3 | 1.62048777 |
| 23 | EIF2AK3 | 1.58422262 |
| 24 | TXK | 1.52928691 |
| 25 | MAP3K12 | 1.52438914 |
| 26 | CSF1R | 1.51121358 |
| 27 | STK16 | 1.48543248 |
| 28 | ZAP70 | 1.43822453 |
| 29 | CLK1 | 1.41742155 |
| 30 | TAOK1 | 1.38305704 |
| 31 | BRSK2 | 1.33880178 |
| 32 | WEE1 | 1.32527601 |
| 33 | LYN | 1.30641699 |
| 34 | CDC7 | 1.27652508 |
| 35 | HCK | 1.23924470 |
| 36 | JAK1 | 1.23737048 |
| 37 | KSR2 | 1.22691030 |
| 38 | IKBKB | 1.22171159 |
| 39 | TESK1 | 1.21127010 |
| 40 | BUB1 | 1.20751162 |
| 41 | JAK3 | 1.18665583 |
| 42 | PIM1 | 1.17216016 |
| 43 | CSK | 1.16564414 |
| 44 | MAP3K1 | 1.15200333 |
| 45 | TRPM7 | 1.14808712 |
| 46 | FLT3 | 1.13984182 |
| 47 | CDK19 | 1.13938429 |
| 48 | TESK2 | 1.10090395 |
| 49 | EIF2AK2 | 1.09908972 |
| 50 | IRAK2 | 1.07303430 |
| 51 | IRAK1 | 1.07076873 |
| 52 | MAP3K6 | 1.06315047 |
| 53 | EIF2AK1 | 1.05363618 |
| 54 | CAMKK2 | 1.03995318 |
| 55 | ITK | 1.02607970 |
| 56 | ATR | 1.00263090 |
| 57 | STK4 | 0.99478946 |
| 58 | LCK | 0.96404810 |
| 59 | GRK6 | 0.96372391 |
| 60 | SIK3 | 0.94082982 |
| 61 | PDK1 | 0.92046719 |
| 62 | ABL2 | 0.90908109 |
| 63 | NME2 | 0.88909649 |
| 64 | MAP3K2 | 0.88808803 |
| 65 | ERBB3 | 0.87682882 |
| 66 | STK10 | 0.86049509 |
| 67 | RPS6KA4 | 0.85256099 |
| 68 | YES1 | 0.84523872 |
| 69 | NEK2 | 0.84307980 |
| 70 | EPHB1 | 0.83924736 |
| 71 | VRK1 | 0.83778528 |
| 72 | MATK | 0.81771646 |
| 73 | RPS6KA6 | 0.79591552 |
| 74 | PAK4 | 0.79245863 |
| 75 | PDPK1 | 0.77006475 |
| 76 | CDK4 | 0.76606546 |
| 77 | MARK2 | 0.76192479 |
| 78 | PRKCD | 0.76049528 |
| 79 | MAPK4 | 0.75901499 |
| 80 | SCYL2 | 0.75390110 |
| 81 | RPS6KL1 | 0.74764894 |
| 82 | RPS6KC1 | 0.74764894 |
| 83 | NEK9 | 0.74069224 |
| 84 | TAOK2 | 0.71219449 |
| 85 | JAK2 | 0.70529942 |
| 86 | GRK7 | 0.68933990 |
| 87 | PTK2B | 0.68003544 |
| 88 | FYN | 0.66355581 |
| 89 | MAP3K8 | 0.63312909 |
| 90 | CDK6 | 0.62385361 |
| 91 | DAPK1 | 0.60387340 |
| 92 | MAPK12 | 0.60380234 |
| 93 | MAPK7 | 0.60302215 |
| 94 | CHUK | 0.59671574 |
| 95 | CCNB1 | 0.59362544 |
| 96 | FGFR3 | 0.57405014 |
| 97 | RPS6KA2 | 0.56676022 |
| 98 | ABL1 | 0.56185250 |
| 99 | MAP3K5 | 0.55479501 |
| 100 | CDK7 | 0.54659422 |
| 101 | MAP2K4 | 0.53086903 |
| 102 | RAF1 | 0.52355498 |
| 103 | LRRK2 | 0.51699175 |
| 104 | PIK3CG | 0.51080415 |
| 105 | PLK4 | 0.50794100 |
| 106 | CDK8 | 0.50508658 |
| 107 | TTN | 0.50048379 |
| 108 | AURKB | 0.49489488 |
| 109 | SGK3 | 0.48844486 |
| 110 | BRSK1 | 0.48313651 |
| 111 | BMPR2 | 0.47874522 |
| 112 | STK11 | 0.47618146 |
| 113 | DYRK1B | 0.47596017 |
| 114 | KSR1 | 0.46998273 |
| 115 | MOS | 0.46133308 |
| 116 | PRKCQ | 0.45866082 |
| 117 | PKN2 | 0.45173621 |
| 118 | PTK6 | 0.45085683 |
| 119 | MAP3K7 | 0.43715078 |
| 120 | PBK | 0.43657252 |
| 121 | MAP3K13 | 0.43234108 |
| 122 | SRPK1 | 0.42596048 |
| 123 | HIPK2 | 0.42288714 |
| 124 | RET | 0.41820988 |
| 125 | CAMKK1 | 0.40229130 |
| 126 | ACVR1B | 0.39722062 |
| 127 | CDC42BPA | 0.39496557 |
| 128 | DAPK2 | 0.39392475 |
| 129 | PRKD2 | 0.38321120 |
| 130 | SGK2 | 0.37794513 |
| 131 | EGFR | 0.37040974 |
| 132 | TGFBR2 | 0.35833115 |
| 133 | MAP3K11 | 0.35588419 |
| 134 | MAPKAPK2 | 0.34987542 |
| 135 | PLK1 | 0.34925295 |
| 136 | MAP2K6 | 0.32110854 |
| 137 | SIK2 | 0.31121355 |
| 138 | WNK1 | 0.31110651 |
| 139 | TTK | 0.29862529 |
| 140 | CHEK2 | 0.28460699 |
| 141 | MARK3 | 0.27989997 |
| 142 | PRKD1 | 0.21589454 |
| 143 | NLK | 0.21484597 |
| 144 | EPHA3 | 0.20192040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.40934842 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.80441727 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.67124418 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.59564626 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.55730009 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.51567455 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40562461 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22671469 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.21081930 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19332366 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12003274 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.11625907 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.11371388 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.03715309 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02275097 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.99855860 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92723820 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90878928 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.84633334 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.82703644 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.75704721 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.72866614 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72394777 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70557276 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65116079 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.64675755 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64286677 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51202214 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50317566 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.47966182 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47644403 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.45134243 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.38996134 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.37772442 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35511146 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.29997220 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.29950552 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27177086 |
| 39 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26839807 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23324828 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18673139 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16999595 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16470010 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14501668 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07803150 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.06372595 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.05830220 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05674207 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05583089 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04217844 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04158144 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02473775 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01487816 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99601327 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99024120 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.97924180 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96899177 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93219619 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84382155 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83694527 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82080906 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.78481477 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78256055 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77140648 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74977039 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73090026 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72085147 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.72075659 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72017813 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70462209 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69946493 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69438563 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68701749 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67876434 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.67117631 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66983143 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65439418 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64619036 |
| 79 | Proteasome_Homo sapiens_hsa03050 | 0.62605517 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62507000 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.62218196 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61784621 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61069246 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.61036271 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60933207 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60721456 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59888071 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56755161 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56445486 |
| 90 | Ribosome_Homo sapiens_hsa03010 | 0.55808529 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53975344 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53682474 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52596626 |
| 94 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52428814 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52105592 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51630915 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51628093 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51445947 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49584967 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49557476 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49214042 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48526689 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48311468 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48150642 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47761097 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47357252 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.46305781 |
| 108 | Spliceosome_Homo sapiens_hsa03040 | 0.45380883 |
| 109 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44553733 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43616517 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43399913 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42109130 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41577079 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39816038 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39731893 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37533449 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36176625 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35947756 |
| 119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35543658 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35391281 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35295691 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34725062 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34592449 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33826448 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33648715 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33093483 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.32965266 |
| 128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32525294 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32314625 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30574653 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30072069 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30014136 |

